required for life hemoglobin cytochromes DNA repair catalase iron fortification
Using Iron Porphyrins as Models for Hemoglobin
description
Transcript of Using Iron Porphyrins as Models for Hemoglobin
Using Iron Porphyrins as Models for Hemoglobin
The system:
Key Features of Hemes• Fe oxidation state• Fe spin state• porphyrin oxidation state• porphyrin hydrophobicity
Low Spin S = 1/2 n = 1
High Spin S = 5/2 n = 5
Intermediate Spin S = 3/2 n = 3
How will the spin state of Fe(porphyrin) complexes change on binding imidazole?
Sample for Evans’ Magnetic Susceptibility Method
Inside capillary: sample in CHCl3, 1) with imidazole 2) without imidazole
Outside capillary: CDCl3 and CHCl3
NMR tube
NMR Spectrum from Evans’ Method
Inside capillary: sample in CHCl3,
produces broad singlet for paramagnetically shifted CHCl3 below 7.3 ppm
Outside capillary: CDCl3 and CHCl3
produces usual sharp singlet for 0.5% CHCl3 at 7.3 ppm
Why is H resonance in CHCl3 shifted downfield and broadened?
• pseudocontact and contact terms• addition of new small magnetic field to local magnetic fields of neighboring nuclei
is used in NMR Shift Reagents to “de-tangle” complicated spectra
How does shift, , relate to a magnetization of paramagnetic sample?
g = 3 0 c
Mass susceptibility (+)
Shift of signal, in Hz
mass susceptibility of solvent-a diamagnetic contribution, a (-) value
Magnetic field(400 MHz, or 400 x 106 Hz)
Concentration of sample,in g/mL
Magnetic field lines of flux
Magnetic field linesaffected by a paramagneticsubstance: attractsSusceptibility, X > 0
Magnetic field linesaffected by a diamagneticsubstance: repelsSusceptibility, X < 0
How does mass susceptibility, g , relate to unpaired electrons in a paramagnetic sample?
g x (Mol. Wt.) = M
corr = M - diamagnetic corrections
where diamagnetic corrections for Fe, porphyrin, Cl, imidazole, a negative number!
eff = 3 R T corr 1/2 = 2.828 (T corr ) 1/2
N 2
eff = (n(n+2))1/2
Mass susceptibility Molar susceptibility
Diamagnetic Corrections (cgs units)
Xo (CHCl3) = - 4.97 x 10-7 cgs
Porphyrin: TPP= -700 x 10-6 cgs TTP= -753 x 10-6 cgs TClPP= -760 x 10-6 cgs
Fe = -13 x 10-6 cgs
Cl = -20 x 10-6 cgs
Imidazole = -38 x 10-6 cgs
The Role of Axial Ligation and the Allosteric Effect in Hemoglobin O2 Binding
3d orbitalson Fe
Spin State of Fe affects size of ion
Large, high spin
Fe(2+):
In T state, transmitted by His on protein helix
Small, low spin
Fe(2+):
In R state, transmitted to His
on protein helix
How Magnetic Nuclei Benefit NMR Experiments
Use of Cr(acac)3 as a Paramagnetic Relaxation Agent
With Cr(acac)3 (note: does not affect chemical shifts)
With d1=6.0s (d1: relaxation time)
Use of Cr(acac)3 as a Paramagnetic Relaxation Agent in 13C NMR
Use of Paramagnetic NMR in Bioinorganic Systems
v
v
m
m
m
p p
One big mess of piled up H’son protein!!
NMR Paramagnetic Shift Reagents
Ground state electron configuration: [Xe] 4f7 6s2
Term Symbol: 8S7/2 how many unpaired e-?
EuFOD :also called Eu(fod)3.
Eu(OCC(CH3)3CHCOC3F7)3
NMR Paramagnetic Shift Reagents: Eu vs Pr
Using Eu(fod)3
Using Pr(fod)3
With NOShift rgt
Hmmm, not so pretty
oooh! Lovely!!
Huh? – signals shifted upfield with Pr
Gadoteric acid
Effect of contrast agent on images: Defect of the blood–brain barrier after stroke shown in MRI. T1-weighted images, left image without, right image with contrast medium administration.
MRI Contrast agents: same principles, applied to medicine
• MRI Contrast Agents: observes differential magnetization of protons in different types of molecules that predominate in different tissues. The different magnetization signal intensities produce the contrast between tissues.
• The nuclear magnetization is produced by the pulse sequence applied, by the density of nuclear spins sub-fractions (water vs fat protons) and by the spin-lattice relaxation time T1 and phase relaxation time T2 in each nuclear spin sub-fraction. T1 and T2 depend on tissues type.
• MRI Contrast Agents interact with one sub-fraction type (usually that easily exchangeable protons, like water) to increase the T1 spin-lattice relaxation times.
• The most commonly used compounds for contrast enhancement are gadolinium-based.
• MRI contrast agents are used as oral or intravenous administration.